This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Validation of Sodergren Score for Haemorrhoids in Malaysia

This study is currently recruiting participants.
See Contacts and Locations
Verified January 2017 by Galen Sha, University of Malaya
Information provided by (Responsible Party):
Galen Sha, University of Malaya Identifier:
First received: August 22, 2016
Last updated: January 17, 2017
Last verified: January 2017
To validate the ability of the Sodergren score in guiding the management of symptomatic haemorrhoids in a Malaysian population.


Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Validating the Ability of the Sodergren Score to Guide Management of Symptomatic Haemorrhoids in a Malaysian Population

Resource links provided by NLM:

Further study details as provided by Galen Sha, University of Malaya:

Primary Outcome Measures:
  • Method of treatment [ Time Frame: 12 months ]
    Surgery or ambulatory treatment of hemorrhoid

Estimated Enrollment: 500
Study Start Date: January 2017
Estimated Study Completion Date: December 2018
Estimated Primary Completion Date: October 2018 (Final data collection date for primary outcome measure)
Symptomatic Hemorrhoid
Consecutive patients with symptomatic hemorrhoids presenting to our clinic

Detailed Description:
All participating, consented subjects will be scored with the Sodergren score prior to receiving a standardized ambulatory treatment regime. The questionnaire will be self-administered by the subjects. Subjects whom are not able to self-administer the questionnaire will be assisted by the investigator or research assistant. The nature and severity of the subject's haemorrhoidal symptoms are considered as the pre-treatment baseline. A follow up period of 12 months will be carried out post treatment for failure or success of treatment. The data collected will be compared to pre-treatment scores and analyzed statistically.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Consecutive patients at specialist clinics

Inclusion Criteria:

  • 18 years of age and older
  • Male and female genders
  • Previous ambulatory treatment
  • Internal Haemorrhoids

Exclusion Criteria:

  • Presence of external haemorrhoids
  • Prior haemorrhoidal surgery
  • Anti-coagulant therapy
  • Anal fissure
  • Inflammatory bowel disease
  • Underlying colon-rectal malignancy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT02884076

Contact: Hon Leong Sha, MD +60123073618

HRPB Recruiting
Ipoh, Perak, Malaysia, 30450
Contact: Hon Leong Sha, MD    +60123073618   
Sponsors and Collaborators
University of Malaya
Principal Investigator: Hon Leong Sha, MD University of Malaya
  More Information

Responsible Party: Galen Sha, Dr, University of Malaya Identifier: NCT02884076     History of Changes
Other Study ID Numbers: Sodergren Validation
Study First Received: August 22, 2016
Last Updated: January 17, 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Keywords provided by Galen Sha, University of Malaya:
Sodergren score

Additional relevant MeSH terms:
Rectal Diseases
Intestinal Diseases
Gastrointestinal Diseases
Digestive System Diseases
Vascular Diseases
Cardiovascular Diseases processed this record on September 21, 2017